Vision and Imaging Tests for Early and Intermediate AMD
Part of Eyes & vision clinical trials.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 55 or older (or 18+ if you have no AMD)
- Able to understand German or English
- Willing to undergo dark-adaptation procedures (your eyes adjusting to darkness)
- No severe eye surgery history in the study eye (cataract surgery is okay)
- No allergy to iodine or contrast dyes used in eye imaging
- Not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
This study is creating a library of eye images to help doctors better diagnose age-related macular degeneration (AMD). You can join if you have healthy eyes or any stage of AMD that has never been treated.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
Hear when a new Age - Related Macular Degeneration (AMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.